List of redirects
Jump to navigation
Jump to search
Showing below up to 50 results in range #8,641 to #8,690.
- C1 esterase inhibitor → C1-inhibitor
- C21-hydroxylase deficiency → 21-Hydroxylase Deficiency
- C3 Glomerulopathy → C3 glomerulopathy
- C3 convertase → C3-convertase
- C3 disease → C3 glomerulopathy
- C3 glomerular disease → C3 glomerulopathy
- C3 glomerular nephropathy → C3 glomerulopathy
- C3 glomerulonephritis → C3 glomerulopathy
- C3 nephritis → C3 glomerulopathy
- C3 nephropathy → C3 glomerulopathy
- C3 renal disease → C3 glomerulopathy
- C3 renal disorder → C3 glomerulopathy
- C4 disease → C4 glomerulopathy
- C4 glomerular disease → C4 glomerulopathy
- C4 glomerulonephritis → C4 glomerulopathy
- C4 nephritis → C4 glomerulopathy
- C4 nephropathy → C4 glomerulopathy
- C4 photosynthesis → C4 carbon fixation
- C4 renal disease → C4 glomerulopathy
- C4 renal disorder → C4 glomerulopathy
- C4b → Complement component 4
- C5b → Complement component 5
- CA-125 test → CA-125
- CA1 → Hippocampus anatomy
- CA125 → CA-125
- CA19-9 → CA 19-9
- CABG → Coronary artery bypass surgery
- CABG PATCH → The Coronary Artery Bypass Graft Patch Trial
- CABG Patch Cardioplegia Substudy → Does Cardioplegia Type Affect Outcome And Survival In Patients With Advanced Left Ventricular Dysfunction? Results From The Cabg Patch Tria
- CABRI → Coronary Angioplasty Versus Bypass Revascularization Investigation
- CACAF → Catheter Ablation For The Cure Of Atrial Fibrillation Study
- CACH → Leukoencephalopathy with vanishing white matter
- CACHET → Comparison Of Abciximab Complications With Hirulog (Angiomax As Of 1999) Ischemic Events Trial
- CACNA1A → Cav2.1
- CACNA1c → CACNA1C
- CACTUS → Coronary Bifurcations: Application Of The Crushing Technique Using Sirolimus-Eluting Stents
- CAC score → Coronary artery calcium scoring
- CAC scoring → Coronary artery calcium scoring
- CAD → Coronary heart disease
- CADILLAC → Controlled Abciximab (Reopro) And Device Investigation To Lower Late Angioplasty Complications
- CAD prevention → Coronary heart disease prevention
- CAD risk factors → Coronary heart disease risk factors
- CAD risk stratification → Coronary heart disease risk stratification
- CAE → Childhood absence epilepsy
- CAESAR → Canada, Australia, Europe, South Africa Aids Study
- CAF → Coronary artery fistula
- CAFA → Canadian Atrial Fibrillation Anticoagulation Study
- CAFE → Conduit Artery Function Evaluation
- CAH → Congenital adrenal hyperplasia
- CAH1 → 21-hydroxylase deficiency